AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • July 17th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 17th, 2024 Company Industry JurisdictionTHIS AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of July 16, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).